查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1717093

醫療設備報銷市場（按付款人展望、設備類型、設備分類、應用和最終用戶）—2025-2030 年全球預測

Medical Devices Reimbursement Market by Payer Outlook, Device Type, Device Classification, Application, End-User - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 188 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2024 年醫療設備報銷市場價值將達到 5,748 億美元，到 2025 年將成長至 6,182.5 億美元，複合年成長率為 7.73%，到 2030 年將達到 8987.8 億美元。

主要市場統計數據
基準年2024年 5748億美元
預計2025年 6182.5億美元
預測年份 2030 8987.8億美元
複合年成長率（%） 7.73%

在當今快速發展的醫療保健環境中，了解醫療設備報銷的複雜性對於策略和營運成功至關重要。這項全面的分析深入探討了影響報銷流程和醫療設備金融生態系統的關鍵因素。它強調了監管變化、技術創新和付款人動態的變化將如何影響報銷策略。

所考慮的背景不僅是由先進治療方法和設備的引入所定義的，而且還由平衡成本效益和提供優質醫療服務的新挑戰所定義。包括政策制定者、醫療保健提供者和製造商在內的多方相關人員在決策流程中日益緊密地聯繫在一起，以確保財務模型能夠支持創新和永續性。

本報告深入探討了市場促進因素、固有監管風險和未來趨勢。它整合了當前的市場訊息，並提供了關鍵細分市場如何適應當代挑戰的見解。透過深入的分析和前瞻性的觀點，它旨在為決策者提供資訊和權力，為應對醫療設備複雜的報銷動態提供堅實的基礎。

市場動態正處於轉折點

該行業已經經歷了一場轉型轉變，重新定義傳統模式並加快報銷模式演變的步伐。經濟壓力和快速的技術創新開始在改變報銷格局方面發揮關鍵作用。

近年來，醫療照護已轉向以價值為基礎的模式，這種模式更注重績效和結果而非數量。遠端醫療平台和人工智慧診斷工具等數位健康技術的整合正在進一步加速這一變化。這些進步正在將醫療保健報銷模式從靜態的按服務收費安排轉變為獎勵效率、優質結果和以患者為中心的護理的更細緻的框架。

監管機構也重新調整了評估方法，更加重視臨床效果和長期成本節約。因此，製造商必須調整產品系列以滿足更嚴格的基準並滿足不斷變化的付款人期望。隨著相關人員探索承諾共用擔風險​​和回報的創新合約安排，人們越來越重視綜合照護模式。總的來說，這些轉型轉變強調了在不斷變化的環境中取得成功需要敏捷和前瞻性的方法。

推動產業趨勢的關鍵細分洞察

對市場區隔的詳細評估為理解影響報銷策略的眾多因素提供了重要的藍圖。分析首先檢視付款人格局，將市場分為私人市場和公共市場。這種二分法有助於理解每個付款人固有的不同報銷標準和經濟預期。

此外，觀察不同類型的醫療設備就會發現其結構是多方面的。我們從消耗品和一次性用品、診斷影像設備、行動輔助設備和治療設備的角度研究市場。消耗品和一次性用品受到嚴格審查，注射器、針頭和創傷護理產品等關鍵物品受到審查。影像設備又細分為CT掃描儀、磁振造影設備、超音波設備和X光設備，它們共同代表技術創新。治療設備分析包括透析設備、輸液系統和呼吸治療設備，其中呼吸治療設備又細分為氧氣療法設備和人工呼吸器，突顯了呼吸照護的重要性。

此外，根據設備分類的審查將產品分為 I 類、II 類和 III 類。基於應用的細分更深入地研究了心臟病學、神經病學、腫瘤學和整形外科領域。這裡，循環系統進一步分為心律管理設備和介入性循環系統設備，神經科為腦脊髓液管理設備和神經刺激設備，腫瘤學分為化療管理設備和放射治療設備，整形外科分為關節重組設備和脊椎外科設備。最後，對最終用戶進行調查，包括門診手術中心、家庭醫療保健和醫院/診所，後者進一步細分為住院患者和門診病人。這種細分提供了對市場促進因素和市場差距的詳細了解。

目錄

第1章 引言

第2章調查方法

第3章執行摘要

第4章 市場概述

第5章 市場洞察

  • 市場動態
    • 驅動程式
      • 需要專門設備的慢性病增多
      • 政府和私部門增加醫療支出
    • 限制因素
      • 消費者對獲得核准和確定報銷資格的擔憂
    • 機會
      • 隨著遠端醫療和數位健康解決方案的擴展，連網型設備的興起
    • 任務
      • 在設備使用和報銷方面對保護患者資料的擔憂
  • 市場區隔分析
    • 付款人觀點：公共付款人對廣泛獲取和標準化流程的重要性
    • 最終用戶：醫院和診所利用醫療設備報銷來滿足不同病患的需求
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 經濟
    • 社會
    • 技術的
    • 合法的
    • 環境

第6章醫療設備報銷市場（以付款人分類）展望

  • 私人的
  • 公共

第7章醫療設備報銷市場（依設備類型）

  • 消耗品和一次性用品
    • 注射器和針頭
    • 創傷護理產品
  • 診斷影像設備
    • 電腦斷層掃描（CT）掃描儀
    • 磁振造影（MRI）設備
    • 超音波設備
    • X光系統
  • 助行輔助器
  • 處理設備
    • 透析設備
    • 輸液系統
    • 呼吸治療設備
      • 氧氣療法設備
      • 人工呼吸器

第8章醫療設備報銷市場（依設備分類）

  • I類
  • II 類
  • III 類

第9章醫療設備報銷市場（按應用）

  • 心臟病學
    • 心律管理
    • 介入心臟器械
  • 神經病學
    • 腦脊髓液管理
    • 神經刺激設備
  • 腫瘤學
    • 化療的實施
    • 放射治療設備
  • 整形外科
    • 關節重組
    • 脊椎手術設備

第 10 章醫療設備報銷市場（按最終用戶）

  • 門診手術中心
  • 家庭醫療保健
  • 醫院和診所
    • 住院護理
    • 門診護理

第 11 章：美洲醫療設備報銷市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

12. 亞太醫療設備報銷市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

13. 歐洲、中東和非洲醫療設備報銷市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第14章競爭格局

  • 2024年市場佔有率分析
  • 2024年FPNV定位矩陣
  • 競爭情境分析
  • 戰略分析與建議

公司名單

  • AiM GmbH
  • Allianz SE
  • Anco Insurance
  • Anthem Insurance Companies, Inc.
  • Aviva PLC
  • BNP Paribas
  • CVS Health Corporation
  • European Med Tech and IVD Reimbursement Consulting Ltd.
  • Hamilton Leigh Ltd.
  • HUB International Limited
  • Humana Inc.
  • MCRA, LLC
  • mdiConsultants, Inc.
  • Medmarc Insurance Group
  • North American Science Associates, Inc.
  • Reliance Nippon Life Insurance Company
  • UnitedHealth Group
  • UnitedHealth Group Incorporated
  • WellCare Health Plans, Inc.
  • WS Value & Dossier GmbH
  • XIFIN, Inc.
Product Code: MRR-205091A88A65

The Medical Devices Reimbursement Market was valued at USD 574.80 billion in 2024 and is projected to grow to USD 618.25 billion in 2025, with a CAGR of 7.73%, reaching USD 898.78 billion by 2030.

KEY MARKET STATISTICS
Base Year [2024] USD 574.80 billion
Estimated Year [2025] USD 618.25 billion
Forecast Year [2030] USD 898.78 billion
CAGR (%) 7.73%

In today's rapidly evolving healthcare environment, understanding the complexities of medical devices reimbursement is critical for strategic planning and operational success. This comprehensive analysis delves into the critical factors shaping reimbursement processes and the financial ecosystem surrounding medical devices. It highlights how reimbursement strategies are increasingly influenced by regulatory changes, technological innovations, and shifts in payer dynamics.

The landscape under review is not only defined by the introduction of advanced treatments and devices but also by the emerging challenges in aligning cost efficiency with high-quality healthcare delivery. Several stakeholders, including policymakers, healthcare providers, and manufacturers, are now more intertwined in the decision-making process, ensuring that financial models support both innovation and sustainability.

This report provides an in-depth exploration of market drivers, inherent regulatory risks, and future trends. It synthesizes current market intelligence and offers insights into how key market segments are adapting to contemporary challenges. Through detailed analysis and a forward-looking perspective, the discussion aims to inform and empower decision-makers, offering them a robust foundation to navigate the intricate reimbursement dynamics in medical devices.

Transformative Shifts in the Market Dynamics

The industry has witnessed transformative shifts that have redefined traditional models and accelerated the pace at which reimbursement paradigms evolve. Increasingly, economic pressures and rapid technological innovations have played a significant role in altering the reimbursement landscape.

Recent years have seen a migration toward value-based care which encourages performance and outcomes rather than sheer volume. The integration of digital health technologies, including telemedicine platforms and AI-driven diagnostic tools, has further catalyzed these changes. These advancements have transitioned reimbursement models from static fee-for-service arrangements to more nuanced frameworks that reward efficiency, quality outcomes, and patient-centered care.

Regulatory bodies have also recalibrated their assessment methodologies, placing greater emphasis on clinical efficacy and long-term cost savings. As a result, manufacturers have had to tailor their product portfolios to meet stricter benchmarks and to align with evolving payer expectations. Emphasis on integrated care models is increasingly evident, as stakeholders explore innovative contractual arrangements that promise shared risk and reward. Overall, these transformative shifts emphasize the need for agility and a forward-thinking approach in order to thrive amidst an ever-changing landscape.

Critical Segmentation Insights Driving Industry Trends

A detailed evaluation of market segmentation provides an essential blueprint for understanding the myriad factors influencing reimbursement strategies. The analysis begins by looking at payer outlooks which categorizes the market into private and public segments. Such bifurcation makes it possible to appreciate the different reimbursement criteria and financial expectations intrinsic to each payer.

Further, an examination based on device type reveals a multifaceted structure. The market is studied through the lens of consumables and disposables, diagnostic imaging equipment, mobility aids, and therapeutic devices. In-depth scrutiny of consumables and disposables breaks out key items like syringes and needles as well as wound care products. Diagnostic imaging equipment is further subdivided into computed tomography scanners, magnetic resonance imaging equipment, ultrasound devices, and X-ray systems which collectively showcase technological innovations. Therapeutic devices are analyzed by considering dialysis equipment, infusion systems, and respiratory therapy devices; the latter is intricately divided into oxygen therapy equipment and ventilators, emphasizing the critical nature of respiratory care.

Additionally, a review based on device classification segments products into Class I, Class II, and Class III. The application-based segmentation takes a closer look at the areas of cardiology, neurology, oncology, and orthopedics. Here, cardiology is further segmented into cardiac rhythm management and interventional cardiology devices, neurology into cerebrospinal fluid management and neurostimulation devices, oncology into chemotherapy administration and radiation therapy equipment, while orthopedics is bifurcated into joint reconstruction and spinal surgery devices. Finally, when considering end-users, the framework examines ambulatory surgical centers, home healthcare, and hospitals and clinics where the latter is further segmented into in-patient and out-patient care. These segmentation insights afford a granular appreciation of market drivers and disparities.

Based on Payer Outlook, market is studied across Private and Public.

Based on Device Type, market is studied across Consumables and Disposables, Diagnostic Imaging Equipment, Mobility Aids, and Therapeutic Devices. The Consumables and Disposables is further studied across Syringes & Needles and Wound Care Products. The Diagnostic Imaging Equipment is further studied across Computed Tomography (CT) Scanners, Magnetic Resonance Imaging (MRI) Equipment, Ultrasound Devices, and X-Ray Systems. The Therapeutic Devices is further studied across Dialysis Equipment, Infusion Systems, and Respiratory Therapy Devices. The Respiratory Therapy Devices is further studied across Oxygen Therapy Equipment and Ventilators.

Based on Device Classification, market is studied across Class I, Class II, and Class III.

Based on Application, market is studied across Cardiology, Neurology, Oncology, and Orthopedics. The Cardiology is further studied across Cardiac Rhythm Management and Interventional Cardiology Devices. The Neurology is further studied across Cerebrospinal Fluid Management and Neurostimulation Devices. The Oncology is further studied across Chemotherapy Administration and Radiation Therapy Equipment. The Orthopedics is further studied across Joint Reconstruction and Spinal Surgery Devices.

Based on End-User, market is studied across Ambulatory Surgical Centers, Home Healthcare, and Hospitals & Clinics. The Hospitals & Clinics is further studied across In-patient Care and Out-patient Care.

Regional Dynamics and Growth Opportunities in Global Markets

The global medical devices reimbursement arena is marked by significant regional diversity, which in turn shapes strategic investment and operational priorities. The analysis draws on recent trends observed across major regions. In the Americas, evolving payer models and increasing adoption of advanced technologies have reshaped market dynamics, spurring both innovation and competitive pricing structures.

In the Europe, Middle East & Africa region, a rich blend of regulatory frameworks and diverse economic conditions has resulted in a unique mix of challenges and opportunities. Stakeholders in this region benefit from concerted efforts toward regulatory harmonization coupled with market-driven reforms that foster enhanced interconnectivity between healthcare providers and insurers.

The Asia-Pacific region stands out as a hotbed of growth, marked by rapidly evolving infrastructure, a rising middle class, and increasing healthcare expenditures. This dynamic environment provides fertile ground for both established and emerging players to capitalize on new market segments. The nuanced differences and similarities across these regions underline the importance of a tailored strategic approach to meet localized demands while maintaining a global perspective.

Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

Insightful Analysis of Prominent Market Players and Their Strategies

The competitive landscape is defined by a diverse set of companies that bring varying strengths and strategic orientations to the table. Market leaders demonstrate a rich tapestry of innovation, risk management, and flexible service offerings, which redefines success in reimbursement strategies. Established firms such as AiM GmbH and Allianz SE have carved out leadership positions by leveraging their deep market expertise and maintaining a strong commitment to quality. Other major stakeholders including Anco Insurance and Anthem Insurance Companies, Inc. have successfully aligned their strategies with emerging digital trends and regulatory expectations, thereby fortifying their market presence.

Furthermore, companies like Aviva PLC, BNP Paribas, and CVS Health Corporation remain at the forefront of shaping market directions through collaborative initiatives and integrated service models. European Med Tech and IVD Reimbursement Consulting Ltd. and Hamilton Leigh Ltd. are distinguished by their focused approach on bridging clinical innovations with reimbursement realities. HUB International Limited and Humana Inc., along with MCRA, LLC and mdiConsultants, Inc., have expanded their expertise by closely monitoring evolving payer dynamics. Medmarc Insurance Group and North American Science Associates, Inc. further complement this competitive mix with their commitment to leveraging technology and data analytics. Reliance Nippon Life Insurance Company, UnitedHealth Group and its incorporated counterpart, WellCare Health Plans, Inc., WS Value & Dossier GmbH, and XIFIN, Inc. round out a comprehensive competitive overview, reflecting a blend of approaches that are both innovative and responsive to market changes.

The report delves into recent significant developments in the Medical Devices Reimbursement Market, highlighting leading vendors and their innovative profiles. These include AiM GmbH, Allianz SE, Anco Insurance, Anthem Insurance Companies, Inc., Aviva PLC, BNP Paribas, CVS Health Corporation, European Med Tech and IVD Reimbursement Consulting Ltd., Hamilton Leigh Ltd., HUB International Limited, Humana Inc., MCRA, LLC, mdiConsultants, Inc., Medmarc Insurance Group, North American Science Associates, Inc., Reliance Nippon Life Insurance Company, UnitedHealth Group, UnitedHealth Group Incorporated, WellCare Health Plans, Inc., WS Value & Dossier GmbH, and XIFIN, Inc.. Actionable Strategic Recommendations for Market Leaders

For industry leaders navigating the complex reimbursement terrain, actionable strategies are critical to harness the full potential of market opportunities. It is imperative to invest in advanced data analytics and robust forecasting tools to accurately track market shifts and payer behavior. Enhanced collaboration with regulatory bodies can also pave the way for smoother dossier preparation and faster reimbursement cycles. Integrating bespoke digital solutions, particularly in the realm of telehealth and AI-enhanced diagnostic capabilities, can significantly optimize cost management and operational efficiency.

Furthermore, it is advisable to foster cross-functional partnerships that integrate clinical expertise with commercial acumen. Adopting a customer-centric approach by actively engaging with both private and public payers will enable more nuanced pricing strategies that reflect the true value of medical innovations. Emphasis should be placed on continuous staff training to ensure familiarity with emerging trends and regulatory updates. Leaders are encouraged to benchmark against best practices from peer institutions and to remain agile in strategy recalibration, ensuring that product portfolios remain aligned with evolving reimbursement frameworks.

Conclusion: Strategic Pathways for the Future of Medical Device Reimbursement

In summary, the dynamic landscape of medical devices reimbursement demands a multifaceted approach that is both agile and informed by rigorous market analysis. The critical insights drawn from segmentation, regional diversity, and competitive pressures underscore an industry at a crossroads where traditional models are being redefined by innovation and regulatory shifts. Stakeholders today must balance efficiency with effectiveness in order to respond to the increasing complexity of payer demands and technological innovations.

As the market continues to mature, successful navigation will depend on the ability to anticipate trends and create adaptive strategies that align financial outcomes with clinical benefits. This comprehensive summary reinforces the notion that understanding the interplay between policy, technology, and market segmentation is essential. Ultimately, the future will belong to those who can integrate diverse insights into actionable plans, thereby ensuring sustained growth and improved patient outcomes in the medical devices reimbursement arena.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing prevalence of chronic conditions with need for specialised devices
      • 5.1.1.2. Rising healthcare spending by government and private sectors
    • 5.1.2. Restraints
      • 5.1.2.1. Consumer concerns associated with obtaining approvals and establishing reimbursement eligibility
    • 5.1.3. Opportunities
      • 5.1.3.1. Rise of connected devices with expansion of telemedicine and digital health solutions
    • 5.1.4. Challenges
      • 5.1.4.1. Concerns assocaited with the protection of patient data in the context of device usage and reimbursement
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Payer Outlook: Significance of public payer for broad access and standardized processes
    • 5.2.2. End-User: Utilization of medical devices reimbursement in hospitals & clinics to serve diverse patient needs
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Medical Devices Reimbursement Market, by Payer Outlook

  • 6.1. Introduction
  • 6.2. Private
  • 6.3. Public

7. Medical Devices Reimbursement Market, by Device Type

  • 7.1. Introduction
  • 7.2. Consumables and Disposables
    • 7.2.1. Syringes & Needles
    • 7.2.2. Wound Care Products
  • 7.3. Diagnostic Imaging Equipment
    • 7.3.1. Computed Tomography (CT) Scanners
    • 7.3.2. Magnetic Resonance Imaging (MRI) Equipment
    • 7.3.3. Ultrasound Devices
    • 7.3.4. X-Ray Systems
  • 7.4. Mobility Aids
  • 7.5. Therapeutic Devices
    • 7.5.1. Dialysis Equipment
    • 7.5.2. Infusion Systems
    • 7.5.3. Respiratory Therapy Devices
      • 7.5.3.1. Oxygen Therapy Equipment
      • 7.5.3.2. Ventilators

8. Medical Devices Reimbursement Market, by Device Classification

  • 8.1. Introduction
  • 8.2. Class I
  • 8.3. Class II
  • 8.4. Class III

9. Medical Devices Reimbursement Market, by Application

  • 9.1. Introduction
  • 9.2. Cardiology
    • 9.2.1. Cardiac Rhythm Management
    • 9.2.2. Interventional Cardiology Devices
  • 9.3. Neurology
    • 9.3.1. Cerebrospinal Fluid Management
    • 9.3.2. Neurostimulation Devices
  • 9.4. Oncology
    • 9.4.1. Chemotherapy Administration
    • 9.4.2. Radiation Therapy Equipment
  • 9.5. Orthopedics
    • 9.5.1. Joint Reconstruction
    • 9.5.2. Spinal Surgery Devices

10. Medical Devices Reimbursement Market, by End-User

  • 10.1. Introduction
  • 10.2. Ambulatory Surgical Centers
  • 10.3. Home Healthcare
  • 10.4. Hospitals & Clinics
    • 10.4.1. In-patient Care
    • 10.4.2. Out-patient Care

11. Americas Medical Devices Reimbursement Market

  • 11.1. Introduction
  • 11.2. Argentina
  • 11.3. Brazil
  • 11.4. Canada
  • 11.5. Mexico
  • 11.6. United States

12. Asia-Pacific Medical Devices Reimbursement Market

  • 12.1. Introduction
  • 12.2. Australia
  • 12.3. China
  • 12.4. India
  • 12.5. Indonesia
  • 12.6. Japan
  • 12.7. Malaysia
  • 12.8. Philippines
  • 12.9. Singapore
  • 12.10. South Korea
  • 12.11. Taiwan
  • 12.12. Thailand
  • 12.13. Vietnam

13. Europe, Middle East & Africa Medical Devices Reimbursement Market

  • 13.1. Introduction
  • 13.2. Denmark
  • 13.3. Egypt
  • 13.4. Finland
  • 13.5. France
  • 13.6. Germany
  • 13.7. Israel
  • 13.8. Italy
  • 13.9. Netherlands
  • 13.10. Nigeria
  • 13.11. Norway
  • 13.12. Poland
  • 13.13. Qatar
  • 13.14. Russia
  • 13.15. Saudi Arabia
  • 13.16. South Africa
  • 13.17. Spain
  • 13.18. Sweden
  • 13.19. Switzerland
  • 13.20. Turkey
  • 13.21. United Arab Emirates
  • 13.22. United Kingdom

14. Competitive Landscape

  • 14.1. Market Share Analysis, 2024
  • 14.2. FPNV Positioning Matrix, 2024
  • 14.3. Competitive Scenario Analysis
    • 14.3.1. Inari Medical secures reimbursement for ClotTriever in Japan, partners with Medikit for strategic distribution
    • 14.3.2. UK medical device companies benefit from Medilink and Medical Alley partnership on reimbursement pathways
    • 14.3.3. Medicare's new reimbursement rule enhances market access for FDA breakthrough medical devices
    • 14.3.4. Bipartisan call for CMS to establish a cohesive reimbursement pathway for AI-enabled medical devices
  • 14.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. AiM GmbH
  • 2. Allianz SE
  • 3. Anco Insurance
  • 4. Anthem Insurance Companies, Inc.
  • 5. Aviva PLC
  • 6. BNP Paribas
  • 7. CVS Health Corporation
  • 8. European Med Tech and IVD Reimbursement Consulting Ltd.
  • 9. Hamilton Leigh Ltd.
  • 10. HUB International Limited
  • 11. Humana Inc.
  • 12. MCRA, LLC
  • 13. mdiConsultants, Inc.
  • 14. Medmarc Insurance Group
  • 15. North American Science Associates, Inc.
  • 16. Reliance Nippon Life Insurance Company
  • 17. UnitedHealth Group
  • 18. UnitedHealth Group Incorporated
  • 19. WellCare Health Plans, Inc.
  • 20. WS Value & Dossier GmbH
  • 21. XIFIN, Inc.

LIST OF FIGURES

  • FIGURE 1. MEDICAL DEVICES REIMBURSEMENT MARKET MULTI-CURRENCY
  • FIGURE 2. MEDICAL DEVICES REIMBURSEMENT MARKET MULTI-LANGUAGE
  • FIGURE 3. MEDICAL DEVICES REIMBURSEMENT MARKET RESEARCH PROCESS
  • FIGURE 4. MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, 2024 VS 2030
  • FIGURE 5. GLOBAL MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 6. GLOBAL MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 7. GLOBAL MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY PAYER OUTLOOK, 2024 VS 2030 (%)
  • FIGURE 9. GLOBAL MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY PAYER OUTLOOK, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY DEVICE TYPE, 2024 VS 2030 (%)
  • FIGURE 11. GLOBAL MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY DEVICE TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY DEVICE CLASSIFICATION, 2024 VS 2030 (%)
  • FIGURE 13. GLOBAL MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY DEVICE CLASSIFICATION, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 14. GLOBAL MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
  • FIGURE 15. GLOBAL MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 16. GLOBAL MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY END-USER, 2024 VS 2030 (%)
  • FIGURE 17. GLOBAL MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY END-USER, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 18. AMERICAS MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
  • FIGURE 19. AMERICAS MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 20. UNITED STATES MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY STATE, 2024 VS 2030 (%)
  • FIGURE 21. UNITED STATES MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 22. ASIA-PACIFIC MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
  • FIGURE 23. ASIA-PACIFIC MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 24. EUROPE, MIDDLE EAST & AFRICA MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
  • FIGURE 25. EUROPE, MIDDLE EAST & AFRICA MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 26. MEDICAL DEVICES REIMBURSEMENT MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 27. MEDICAL DEVICES REIMBURSEMENT MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

  • TABLE 1. MEDICAL DEVICES REIMBURSEMENT MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. MEDICAL DEVICES REIMBURSEMENT MARKET DYNAMICS
  • TABLE 7. GLOBAL MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY PAYER OUTLOOK, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY PRIVATE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY PUBLIC, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY CONSUMABLES AND DISPOSABLES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY SYRINGES & NEEDLES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY WOUND CARE PRODUCTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY CONSUMABLES AND DISPOSABLES, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY DIAGNOSTIC IMAGING EQUIPMENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY COMPUTED TOMOGRAPHY (CT) SCANNERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY MAGNETIC RESONANCE IMAGING (MRI) EQUIPMENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY ULTRASOUND DEVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY X-RAY SYSTEMS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY DIAGNOSTIC IMAGING EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY MOBILITY AIDS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY THERAPEUTIC DEVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY DIALYSIS EQUIPMENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY INFUSION SYSTEMS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY RESPIRATORY THERAPY DEVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 26. GLOBAL MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY OXYGEN THERAPY EQUIPMENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 27. GLOBAL MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY VENTILATORS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 28. GLOBAL MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY RESPIRATORY THERAPY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 29. GLOBAL MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY THERAPEUTIC DEVICES, 2018-2030 (USD MILLION)
  • TABLE 30. GLOBAL MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY DEVICE CLASSIFICATION, 2018-2030 (USD MILLION)
  • TABLE 31. GLOBAL MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY CLASS I, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 32. GLOBAL MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY CLASS II, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 33. GLOBAL MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY CLASS III, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 34. GLOBAL MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 35. GLOBAL MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY CARDIOLOGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 36. GLOBAL MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY CARDIAC RHYTHM MANAGEMENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 37. GLOBAL MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY INTERVENTIONAL CARDIOLOGY DEVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 38. GLOBAL MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY CARDIOLOGY, 2018-2030 (USD MILLION)
  • TABLE 39. GLOBAL MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY NEUROLOGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 40. GLOBAL MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY CEREBROSPINAL FLUID MANAGEMENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 41. GLOBAL MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY NEUROSTIMULATION DEVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 42. GLOBAL MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY NEUROLOGY, 2018-2030 (USD MILLION)
  • TABLE 43. GLOBAL MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 44. GLOBAL MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY CHEMOTHERAPY ADMINISTRATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 45. GLOBAL MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY RADIATION THERAPY EQUIPMENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 46. GLOBAL MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
  • TABLE 47. GLOBAL MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY ORTHOPEDICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 48. GLOBAL MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY JOINT RECONSTRUCTION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 49. GLOBAL MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY SPINAL SURGERY DEVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 50. GLOBAL MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY ORTHOPEDICS, 2018-2030 (USD MILLION)
  • TABLE 51. GLOBAL MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 52. GLOBAL MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 53. GLOBAL MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY HOME HEALTHCARE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 54. GLOBAL MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 55. GLOBAL MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY IN-PATIENT CARE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 56. GLOBAL MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY OUT-PATIENT CARE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 57. GLOBAL MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2030 (USD MILLION)
  • TABLE 58. AMERICAS MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY PAYER OUTLOOK, 2018-2030 (USD MILLION)
  • TABLE 59. AMERICAS MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 60. AMERICAS MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY CONSUMABLES AND DISPOSABLES, 2018-2030 (USD MILLION)
  • TABLE 61. AMERICAS MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY DIAGNOSTIC IMAGING EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 62. AMERICAS MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY THERAPEUTIC DEVICES, 2018-2030 (USD MILLION)
  • TABLE 63. AMERICAS MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY RESPIRATORY THERAPY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 64. AMERICAS MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY DEVICE CLASSIFICATION, 2018-2030 (USD MILLION)
  • TABLE 65. AMERICAS MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 66. AMERICAS MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY CARDIOLOGY, 2018-2030 (USD MILLION)
  • TABLE 67. AMERICAS MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY NEUROLOGY, 2018-2030 (USD MILLION)
  • TABLE 68. AMERICAS MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
  • TABLE 69. AMERICAS MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY ORTHOPEDICS, 2018-2030 (USD MILLION)
  • TABLE 70. AMERICAS MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 71. AMERICAS MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2030 (USD MILLION)
  • TABLE 72. AMERICAS MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 73. ARGENTINA MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY PAYER OUTLOOK, 2018-2030 (USD MILLION)
  • TABLE 74. ARGENTINA MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 75. ARGENTINA MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY CONSUMABLES AND DISPOSABLES, 2018-2030 (USD MILLION)
  • TABLE 76. ARGENTINA MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY DIAGNOSTIC IMAGING EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 77. ARGENTINA MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY THERAPEUTIC DEVICES, 2018-2030 (USD MILLION)
  • TABLE 78. ARGENTINA MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY RESPIRATORY THERAPY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 79. ARGENTINA MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY DEVICE CLASSIFICATION, 2018-2030 (USD MILLION)
  • TABLE 80. ARGENTINA MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 81. ARGENTINA MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY CARDIOLOGY, 2018-2030 (USD MILLION)
  • TABLE 82. ARGENTINA MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY NEUROLOGY, 2018-2030 (USD MILLION)
  • TABLE 83. ARGENTINA MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
  • TABLE 84. ARGENTINA MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY ORTHOPEDICS, 2018-2030 (USD MILLION)
  • TABLE 85. ARGENTINA MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 86. ARGENTINA MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2030 (USD MILLION)
  • TABLE 87. BRAZIL MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY PAYER OUTLOOK, 2018-2030 (USD MILLION)
  • TABLE 88. BRAZIL MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 89. BRAZIL MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY CONSUMABLES AND DISPOSABLES, 2018-2030 (USD MILLION)
  • TABLE 90. BRAZIL MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY DIAGNOSTIC IMAGING EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 91. BRAZIL MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY THERAPEUTIC DEVICES, 2018-2030 (USD MILLION)
  • TABLE 92. BRAZIL MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY RESPIRATORY THERAPY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 93. BRAZIL MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY DEVICE CLASSIFICATION, 2018-2030 (USD MILLION)
  • TABLE 94. BRAZIL MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 95. BRAZIL MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY CARDIOLOGY, 2018-2030 (USD MILLION)
  • TABLE 96. BRAZIL MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY NEUROLOGY, 2018-2030 (USD MILLION)
  • TABLE 97. BRAZIL MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
  • TABLE 98. BRAZIL MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY ORTHOPEDICS, 2018-2030 (USD MILLION)
  • TABLE 99. BRAZIL MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 100. BRAZIL MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2030 (USD MILLION)
  • TABLE 101. CANADA MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY PAYER OUTLOOK, 2018-2030 (USD MILLION)
  • TABLE 102. CANADA MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 103. CANADA MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY CONSUMABLES AND DISPOSABLES, 2018-2030 (USD MILLION)
  • TABLE 104. CANADA MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY DIAGNOSTIC IMAGING EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 105. CANADA MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY THERAPEUTIC DEVICES, 2018-2030 (USD MILLION)
  • TABLE 106. CANADA MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY RESPIRATORY THERAPY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 107. CANADA MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY DEVICE CLASSIFICATION, 2018-2030 (USD MILLION)
  • TABLE 108. CANADA MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 109. CANADA MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY CARDIOLOGY, 2018-2030 (USD MILLION)
  • TABLE 110. CANADA MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY NEUROLOGY, 2018-2030 (USD MILLION)
  • TABLE 111. CANADA MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
  • TABLE 112. CANADA MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY ORTHOPEDICS, 2018-2030 (USD MILLION)
  • TABLE 113. CANADA MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 114. CANADA MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2030 (USD MILLION)
  • TABLE 115. MEXICO MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY PAYER OUTLOOK, 2018-2030 (USD MILLION)
  • TABLE 116. MEXICO MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 117. MEXICO MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY CONSUMABLES AND DISPOSABLES, 2018-2030 (USD MILLION)
  • TABLE 118. MEXICO MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY DIAGNOSTIC IMAGING EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 119. MEXICO MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY THERAPEUTIC DEVICES, 2018-2030 (USD MILLION)
  • TABLE 120. MEXICO MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY RESPIRATORY THERAPY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 121. MEXICO MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY DEVICE CLASSIFICATION, 2018-2030 (USD MILLION)
  • TABLE 122. MEXICO MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 123. MEXICO MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY CARDIOLOGY, 2018-2030 (USD MILLION)
  • TABLE 124. MEXICO MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY NEUROLOGY, 2018-2030 (USD MILLION)
  • TABLE 125. MEXICO MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
  • TABLE 126. MEXICO MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY ORTHOPEDICS, 2018-2030 (USD MILLION)
  • TABLE 127. MEXICO MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 128. MEXICO MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2030 (USD MILLION)
  • TABLE 129. UNITED STATES MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY PAYER OUTLOOK, 2018-2030 (USD MILLION)
  • TABLE 130. UNITED STATES MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 131. UNITED STATES MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY CONSUMABLES AND DISPOSABLES, 2018-2030 (USD MILLION)
  • TABLE 132. UNITED STATES MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY DIAGNOSTIC IMAGING EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 133. UNITED STATES MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY THERAPEUTIC DEVICES, 2018-2030 (USD MILLION)
  • TABLE 134. UNITED STATES MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY RESPIRATORY THERAPY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 135. UNITED STATES MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY DEVICE CLASSIFICATION, 2018-2030 (USD MILLION)
  • TABLE 136. UNITED STATES MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 137. UNITED STATES MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY CARDIOLOGY, 2018-2030 (USD MILLION)
  • TABLE 138. UNITED STATES MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY NEUROLOGY, 2018-2030 (USD MILLION)
  • TABLE 139. UNITED STATES MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
  • TABLE 140. UNITED STATES MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY ORTHOPEDICS, 2018-2030 (USD MILLION)
  • TABLE 141. UNITED STATES MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 142. UNITED STATES MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2030 (USD MILLION)
  • TABLE 143. UNITED STATES MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 144. ASIA-PACIFIC MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY PAYER OUTLOOK, 2018-2030 (USD MILLION)
  • TABLE 145. ASIA-PACIFIC MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 146. ASIA-PACIFIC MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY CONSUMABLES AND DISPOSABLES, 2018-2030 (USD MILLION)
  • TABLE 147. ASIA-PACIFIC MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY DIAGNOSTIC IMAGING EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 148. ASIA-PACIFIC MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY THERAPEUTIC DEVICES, 2018-2030 (USD MILLION)
  • TABLE 149. ASIA-PACIFIC MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY RESPIRATORY THERAPY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 150. ASIA-PACIFIC MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY DEVICE CLASSIFICATION, 2018-2030 (USD MILLION)
  • TABLE 151. ASIA-PACIFIC MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 152. ASIA-PACIFIC MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY CARDIOLOGY, 2018-2030 (USD MILLION)
  • TABLE 153. ASIA-PACIFIC MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY NEUROLOGY, 2018-2030 (USD MILLION)
  • TABLE 154. ASIA-PACIFIC MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
  • TABLE 155. ASIA-PACIFIC MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY ORTHOPEDICS, 2018-2030 (USD MILLION)
  • TABLE 156. ASIA-PACIFIC MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 157. ASIA-PACIFIC MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2030 (USD MILLION)
  • TABLE 158. ASIA-PACIFIC MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 159. AUSTRALIA MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY PAYER OUTLOOK, 2018-2030 (USD MILLION)
  • TABLE 160. AUSTRALIA MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 161. AUSTRALIA MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY CONSUMABLES AND DISPOSABLES, 2018-2030 (USD MILLION)
  • TABLE 162. AUSTRALIA MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY DIAGNOSTIC IMAGING EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 163. AUSTRALIA MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY THERAPEUTIC DEVICES, 2018-2030 (USD MILLION)
  • TABLE 164. AUSTRALIA MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY RESPIRATORY THERAPY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 165. AUSTRALIA MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY DEVICE CLASSIFICATION, 2018-2030 (USD MILLION)
  • TABLE 166. AUSTRALIA MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 167. AUSTRALIA MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY CARDIOLOGY, 2018-2030 (USD MILLION)
  • TABLE 168. AUSTRALIA MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY NEUROLOGY, 2018-2030 (USD MILLION)
  • TABLE 169. AUSTRALIA MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
  • TABLE 170. AUSTRALIA MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY ORTHOPEDICS, 2018-2030 (USD MILLION)
  • TABLE 171. AUSTRALIA MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 172. AUSTRALIA MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2030 (USD MILLION)
  • TABLE 173. CHINA MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY PAYER OUTLOOK, 2018-2030 (USD MILLION)
  • TABLE 174. CHINA MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 175. CHINA MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY CONSUMABLES AND DISPOSABLES, 2018-2030 (USD MILLION)
  • TABLE 176. CHINA MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY DIAGNOSTIC IMAGING EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 177. CHINA MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY THERAPEUTIC DEVICES, 2018-2030 (USD MILLION)
  • TABLE 178. CHINA MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY RESPIRATORY THERAPY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 179. CHINA MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY DEVICE CLASSIFICATION, 2018-2030 (USD MILLION)
  • TABLE 180. CHINA MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 181. CHINA MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY CARDIOLOGY, 2018-2030 (USD MILLION)
  • TABLE 182. CHINA MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY NEUROLOGY, 2018-2030 (USD MILLION)
  • TABLE 183. CHINA MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
  • TABLE 184. CHINA MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY ORTHOPEDICS, 2018-2030 (USD MILLION)
  • TABLE 185. CHINA MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 186. CHINA MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2030 (USD MILLION)
  • TABLE 187. INDIA MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY PAYER OUTLOOK, 2018-2030 (USD MILLION)
  • TABLE 188. INDIA MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 189. INDIA MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY CONSUMABLES AND DISPOSABLES, 2018-2030 (USD MILLION)
  • TABLE 190. INDIA MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY DIAGNOSTIC IMAGING EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 191. INDIA MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY THERAPEUTIC DEVICES, 2018-2030 (USD MILLION)
  • TABLE 192. INDIA MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY RESPIRATORY THERAPY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 193. INDIA MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY DEVICE CLASSIFICATION, 2018-2030 (USD MILLION)
  • TABLE 194. INDIA MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 195. INDIA MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY CARDIOLOGY, 2018-2030 (USD MILLION)
  • TABLE 196. INDIA MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY NEUROLOGY, 2018-2030 (USD MILLION)
  • TABLE 197. INDIA MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
  • TABLE 198. INDIA MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY ORTHOPEDICS, 2018-2030 (USD MILLION)
  • TABLE 199. INDIA MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 200. INDIA MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2030 (USD MILLION)
  • TABLE 201. INDONESIA MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY PAYER OUTLOOK, 2018-2030 (USD MILLION)
  • TABLE 202. INDONESIA MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 203. INDONESIA MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY CONSUMABLES AND DISPOSABLES, 2018-2030 (USD MILLION)
  • TABLE 204. INDONESIA MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY DIAGNOSTIC IMAGING EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 205. INDONESIA MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY THERAPEUTIC DEVICES, 2018-2030 (USD MILLION)
  • TABLE 206. INDONESIA MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY RESPIRATORY THERAPY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 207. INDONESIA MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY DEVICE CLASSIFICATION, 2018-2030 (USD MILLION)
  • TABLE 208. INDONESIA MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 209. INDONESIA MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY CARDIOLOGY, 2018-2030 (USD MILLION)
  • TABLE 210. INDONESIA MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY NEUROLOGY, 2018-2030 (USD MILLION)
  • TABLE 211. INDONESIA MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
  • TABLE 212. INDONESIA MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY ORTHOPEDICS, 2018-2030 (USD MILLION)
  • TABLE 213. INDONESIA MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 214. INDONESIA MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2030 (USD MILLION)
  • TABLE 215. JAPAN MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY PAYER OUTLOOK, 2018-2030 (USD MILLION)
  • TABLE 216. JAPAN MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 217. JAPAN MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY CONSUMABLES AND DISPOSABLES, 2018-2030 (USD MILLION)
  • TABLE 218. JAPAN MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY DIAGNOSTIC IMAGING EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 219. JAPAN MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY THERAPEUTIC DEVICES, 2018-2030 (USD MILLION)
  • TABLE 220. JAPAN MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY RESPIRATORY THERAPY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 221. JAPAN MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY DEVICE CLASSIFICATION, 2018-2030 (USD MILLION)
  • TABLE 222. JAPAN MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 223. JAPAN MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY CARDIOLOGY, 2018-2030 (USD MILLION)
  • TABLE 224. JAPAN MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY NEUROLOGY, 2018-2030 (USD MILLION)
  • TABLE 225. JAPAN MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
  • TABLE 226. JAPAN MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY ORTHOPEDICS, 2018-2030 (USD MILLION)
  • TABLE 227. JAPAN MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 228. JAPAN MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2030 (USD MILLION)
  • TABLE 229. MALAYSIA MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY PAYER OUTLOOK, 2018-2030 (USD MILLION)
  • TABLE 230. MALAYSIA MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 231. MALAYSIA MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY CONSUMABLES AND DISPOSABLES, 2018-2030 (USD MILLION)
  • TABLE 232. MALAYSIA MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY DIAGNOSTIC IMAGING EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 233. MALAYSIA MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY THERAPEUTIC DEVICES, 2018-2030 (USD MILLION)
  • TABLE 234. MALAYSIA MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY RESPIRATORY THERAPY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 235. MALAYSIA MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY DEVICE CLASSIFICATION, 2018-2030 (USD MILLION)
  • TABLE 236. MALAYSIA MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 237. MALAYSIA MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY CARDIOLOGY, 2018-2030 (USD MILLION)
  • TABLE 238. MALAYSIA MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY NEUROLOGY, 2018-2030 (USD MILLION)
  • TABLE 239. MALAYSIA MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
  • TABLE 240. MALAYSIA MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY ORTHOPEDICS, 2018-2030 (USD MILLION)
  • TABLE 241. MALAYSIA MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 242. MALAYSIA MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2030 (USD MILLION)
  • TABLE 243. PHILIPPINES MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY PAYER OUTLOOK, 2018-2030 (USD MILLION)
  • TABLE 244. PHILIPPINES MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 245. PHILIPPINES MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY CONSUMABLES AND DISPOSABLES, 2018-2030 (USD MILLION)
  • TABLE 246. PHILIPPINES MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY DIAGNOSTIC IMAGING EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 247. PHILIPPINES MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY THERAPEUTIC DEVICES, 2018-2030 (USD MILLION)
  • TABLE 248. PHILIPPINES MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY RESPIRATORY THERAPY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 249. PHILIPPINES MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY DEVICE CLASSIFICATION, 2018-2030 (USD MILLION)
  • TABLE 250. PHILIPPINES MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 251. PHILIPPINES MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY CARDIOLOGY, 2018-2030 (USD MILLION)
  • TABLE 252. PHILIPPINES MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY NEUROLOGY, 2018-2030 (USD MILLION)
  • TABLE 253. PHILIPPINES MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
  • TABLE 254. PHILIPPINES MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY ORTHOPEDICS, 2018-2030 (USD MILLION)
  • TABLE 255. PHILIPPINES MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 256. PHILIPPINES MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2030 (USD MILLION)
  • TABLE 257. SINGAPORE MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY PAYER OUTLOOK, 2018-2030 (USD MILLION)
  • TABLE 258. SINGAPORE MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 259. SINGAPORE MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY CONSUMABLES AND DISPOSABLES, 2018-2030 (USD MILLION)
  • TABLE 260. SINGAPORE MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY DIAGNOSTIC IMAGING EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 261. SINGAPORE MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY THERAPEUTIC DEVICES, 2018-2030 (USD MILLION)
  • TABLE 262. SINGAPORE MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY RESPIRATORY THERAPY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 263. SINGAPORE MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY DEVICE CLASSIFICATION, 2018-2030 (USD MILLION)
  • TABLE 264. SINGAPORE MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 265. SINGAPORE MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY CARDIOLOGY, 2018-2030 (USD MILLION)
  • TABLE 266. SINGAPORE MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY NEUROLOGY, 2018-2030 (USD MILLION)
  • TABLE 267. SINGAPORE MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
  • TABLE 268. SINGAPORE MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY ORTHOPEDICS, 2018-2030 (USD MILLION)
  • TABLE 269. SINGAPORE MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 270. SINGAPORE MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2030 (USD MILLION)
  • TABLE 271. SOUTH KOREA MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY PAYER OUTLOOK, 2018-2030 (USD MILLION)
  • TABLE 272. SOUTH KOREA MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 273. SOUTH KOREA MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY CONSUMABLES AND DISPOSABLES, 2018-2030 (USD MILLION)
  • TABLE 274. SOUTH KOREA MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY DIAGNOSTIC IMAGING EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 275. SOUTH KOREA MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY THERAPEUTIC DEVICES, 2018-2030 (USD MILLION)
  • TABLE 276. SOUTH KOREA MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY RESPIRATORY THERAPY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 277. SOUTH KOREA MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY DEVICE CLASSIFICATION, 2018-2030 (USD MILLION)
  • TABLE 278. SOUTH KOREA MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 279. SOUTH KOREA MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY CARDIOLOGY, 2018-2030 (USD MILLION)
  • TABLE 280. SOUTH KOREA MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY NEUROLOGY, 2018-2030 (USD MILLION)
  • TABLE 281. SOUTH KOREA MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
  • TABLE 282. SOUTH KOREA MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY ORTHOPEDICS, 2018-2030 (USD MILLION)
  • TABLE 283. SOUTH KOREA MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 284. SOUTH KOREA MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2030 (USD MILLION)
  • TABLE 285. TAIWAN MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY PAYER OUTLOOK, 2018-2030 (USD MILLION)
  • TABLE 286. TAIWAN MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 287. TAIWAN MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY CONSUMABLES AND DISPOSABLES, 2018-2030 (USD MILLION)
  • TABLE 288. TAIWAN MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY DIAGNOSTIC IMAGING EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 289. TAIWAN MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY THERAPEUTIC DEVICES, 2018-2030 (USD MILLION)
  • TABLE 290. TAIWAN MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY RESPIRATORY THERAPY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 291. TAIWAN MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY DEVICE CLASSIFICATION, 2018-2030 (USD MILLION)
  • TABLE 292. TAIWAN MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 293. TAIWAN MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY CARDIOLOGY, 2018-2030 (USD MILLION)
  • TABLE 294. TAIWAN MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY NEUROLOGY, 2018-2030 (USD MILLION)
  • TABLE 295. TAIWAN MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
  • TABLE 296. TAIWAN MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY ORTHOPEDICS, 2018-2030 (USD MILLION)
  • TABLE 297. TAIWAN MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 298. TAIWAN MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2030 (USD MILLION)
  • TABLE 299. THAILAND MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY PAYER OUTLOOK, 2018-2030 (USD MILLION)
  • TABLE 300. THAILAND MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 301. THAILAND MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY CONSUMABLES AND DISPOSABLES, 2018-2030 (USD MILLION)
  • TABLE 302. THAILAND MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY DIAGNOSTIC IMAGING EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 303. THAILAND MEDICAL DEVICES REIM